NovoTTF Treatment Signatures in Glioblastoma Patients At Autopsy
Status: Recruiting
Location: See location...
Intervention Type: Other, Device
Study Type: Observational
SUMMARY
This study will assess whole brain samples from glioblastoma patients at autopsy to determine the underlying pathological signatures of tumor treatment fields at autopsy.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Newly diagnosed glioblastoma, World Health Organization (WHO) grade IV, patients undergoing TTField therapy.
• Recurrent glioblastoma WHO grade IV, patients undergoing TTField therapy.
Locations
United States
Wisconsin
Froedtert & the Medical College of Wisconsin
RECRUITING
Milwaukee
Contact Information
Primary
Medical College of Wisconsin Cancer Center Clinical Trials Office
cccto@mcw.edu
414-805-8900
Time Frame
Start Date: 2017-06-01
Estimated Completion Date: 2027-05-31
Participants
Target number of participants: 20
Treatments
TTField at Recurrence
TTField at New Diagnosis
Related Therapeutic Areas
Sponsors
Leads: Medical College of Wisconsin